1 Chemotherapy-Induced Nausea and Vomiting Drugs Market Overview 1.1 Chemotherapy-Induced Nausea and Vomiting Drugs Product Scope 1.2 Chemotherapy-Induced Nausea and Vomiting Drugs Segment by Type 1.2.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Type (2016 & 2021 & 2027) 1.2.2 Existing Drugs 1.2.3 Akynzeo (Netupitant-Palonosetron FDC) 1.2.4 Aloxi (Palonosetron) 1.2.5 Emend (Aprepitant) 1.2.6 Kytril Generic (Granisetron) 1.2.7 Zofran Generic (Ondansetron) 1.2.8 Pipeline Drugs 1.2.9 SUSTOL (Granisetron Injection extended release) 1.2.10 Rolapitant 1.3 Chemotherapy-Induced Nausea and Vomiting Drugs Segment by Application 1.3.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Comparison by Application (2016 & 2021 & 2027) 1.3.2 Serotonin Receptor Antagonists 1.3.3 NK1 Receptor Antagonists 1.4 Chemotherapy-Induced Nausea and Vomiting Drugs Market Estimates and Forecasts (2016-2027) 1.4.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Size in Value Growth Rate (2016-2027) 1.4.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Size in Volume Growth Rate (2016-2027) 1.4.3 Global Chemotherapy-Induced Nausea and Vomiting Drugs Price Trends (2016-2027) 2 Chemotherapy-Induced Nausea and Vomiting Drugs Estimates and Forecasts by Region 2.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Size by Region: 2016 VS 2021 VS 2027 2.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Retrospective Market Scenario by Region (2016-2021) 2.2.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Region (2016-2021) 2.2.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Region (2016-2021) 2.3 Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Estimates and Forecasts by Region (2022-2027) 2.3.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Estimates and Forecasts by Region (2022-2027) 2.3.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Forecast by Region (2022-2027) 2.4 Geographic Market Analysis: Market Facts & Figures 2.4.1 North America Chemotherapy-Induced Nausea and Vomiting Drugs Estimates and Projections (2016-2027) 2.4.2 Europe Chemotherapy-Induced Nausea and Vomiting Drugs Estimates and Projections (2016-2027) 2.4.3 China Chemotherapy-Induced Nausea and Vomiting Drugs Estimates and Projections (2016-2027) 2.4.4 Japan Chemotherapy-Induced Nausea and Vomiting Drugs Estimates and Projections (2016-2027) 2.4.5 Southeast Asia Chemotherapy-Induced Nausea and Vomiting Drugs Estimates and Projections (2016-2027) 2.4.6 India Chemotherapy-Induced Nausea and Vomiting Drugs Estimates and Projections (2016-2027) 3 Global Chemotherapy-Induced Nausea and Vomiting Drugs Competition Landscape by Players 3.1 Global Top Chemotherapy-Induced Nausea and Vomiting Drugs Players by Sales (2016-2021) 3.2 Global Top Chemotherapy-Induced Nausea and Vomiting Drugs Players by Revenue (2016-2021) 3.3 Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Chemotherapy-Induced Nausea and Vomiting Drugs as of 2020) 3.4 Global Chemotherapy-Induced Nausea and Vomiting Drugs Average Price by Company (2016-2021) 3.5 Manufacturers Chemotherapy-Induced Nausea and Vomiting Drugs Manufacturing Sites, Area Served, Product Type 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Size by Type 4.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Historic Market Review by Type (2016-2021) 4.1.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Type (2016-2021) 4.1.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Type (2016-2021) 4.1.3 Global Chemotherapy-Induced Nausea and Vomiting Drugs Price by Type (2016-2021) 4.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Estimates and Forecasts by Type (2022-2027) 4.2.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Forecast by Type (2022-2027) 4.2.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Forecast by Type (2022-2027) 4.2.3 Global Chemotherapy-Induced Nausea and Vomiting Drugs Price Forecast by Type (2022-2027) 5 Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Size by Application 5.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Historic Market Review by Application (2016-2021) 5.1.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Application (2016-2021) 5.1.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Application (2016-2021) 5.1.3 Global Chemotherapy-Induced Nausea and Vomiting Drugs Price by Application (2016-2021) 5.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Estimates and Forecasts by Application (2022-2027) 5.2.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Forecast by Application (2022-2027) 5.2.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Forecast by Application (2022-2027) 5.2.3 Global Chemotherapy-Induced Nausea and Vomiting Drugs Price Forecast by Application (2022-2027) 6 North America Chemotherapy-Induced Nausea and Vomiting Drugs Market Facts & Figures 6.1 North America Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Company 6.1.1 North America Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Company (2016-2021) 6.1.2 North America Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Company (2016-2021) 6.2 North America Chemotherapy-Induced Nausea and Vomiting Drugs Sales Breakdown by Type 6.2.1 North America Chemotherapy-Induced Nausea and Vomiting Drugs Sales Breakdown by Type (2016-2021) 6.2.2 North America Chemotherapy-Induced Nausea and Vomiting Drugs Sales Breakdown by Type (2022-2027) 6.3 North America Chemotherapy-Induced Nausea and Vomiting Drugs Sales Breakdown by Application 6.3.1 North America Chemotherapy-Induced Nausea and Vomiting Drugs Sales Breakdown by Application (2016-2021) 6.3.2 North America Chemotherapy-Induced Nausea and Vomiting Drugs Sales Breakdown by Application (2022-2027) 7 Europe Chemotherapy-Induced Nausea and Vomiting Drugs Market Facts & Figures 7.1 Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Company 7.1.1 Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Company (2016-2021) 7.1.2 Europe Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Company (2016-2021) 7.2 Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales Breakdown by Type 7.2.1 Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales Breakdown by Type (2016-2021) 7.2.2 Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales Breakdown by Type (2022-2027) 7.3 Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales Breakdown by Application 7.3.1 Europe 130 Sales Breakdown by Application (2016-2021) 7.3.2 Europe 130 Sales Breakdown by Application (2022-2027) 8 China Chemotherapy-Induced Nausea and Vomiting Drugs Market Facts & Figures 8.1 China Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Company 8.1.1 China Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Company (2016-2021) 8.1.2 China Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Company (2016-2021) 8.2 China Chemotherapy-Induced Nausea and Vomiting Drugs Sales Breakdown by Type 8.2.1 China Chemotherapy-Induced Nausea and Vomiting Drugs Sales Breakdown by Type (2016-2021) 8.2.2 China Chemotherapy-Induced Nausea and Vomiting Drugs Sales Breakdown by Type (2022-2027) 8.3 China Chemotherapy-Induced Nausea and Vomiting Drugs Sales Breakdown by Application 8.3.1 China 153 Sales Breakdown by Application (2016-2021) 8.3.2 China 153 Sales Breakdown by Application (2022-2027) 9 Japan Chemotherapy-Induced Nausea and Vomiting Drugs Market Facts & Figures 9.1 Japan Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Company 9.1.1 Japan Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Company (2016-2021) 9.1.2 Japan Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Company (2016-2021) 9.2 Japan Chemotherapy-Induced Nausea and Vomiting Drugs Sales Breakdown by Type 9.2.1 Japan Chemotherapy-Induced Nausea and Vomiting Drugs Sales Breakdown by Type (2016-2021) 9.2.2 Japan Chemotherapy-Induced Nausea and Vomiting Drugs Sales Breakdown by Type (2022-2027) 9.3 Japan Chemotherapy-Induced Nausea and Vomiting Drugs Sales Breakdown by Application 9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021) 9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027) 10 Southeast Asia Chemotherapy-Induced Nausea and Vomiting Drugs Market Facts & Figures 10.1 Southeast Asia Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Company 10.1.1 Southeast Asia Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Company (2016-2021) 10.1.2 Southeast Asia Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Company (2016-2021) 10.2 Southeast Asia Chemotherapy-Induced Nausea and Vomiting Drugs Sales Breakdown by Type 10.2.1 Southeast Asia Chemotherapy-Induced Nausea and Vomiting Drugs Sales Breakdown by Type (2016-2021) 10.2.2 Southeast Asia Chemotherapy-Induced Nausea and Vomiting Drugs Sales Breakdown by Type (2022-2027) 10.3 Southeast Asia Chemotherapy-Induced Nausea and Vomiting Drugs Sales Breakdown by Application 10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021) 10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027) 11 India Chemotherapy-Induced Nausea and Vomiting Drugs Market Facts & Figures 11.1 India Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Company 11.1.1 India Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Company (2016-2021) 11.1.2 India Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Company (2016-2021) 11.2 India Chemotherapy-Induced Nausea and Vomiting Drugs Sales Breakdown by Type 11.2.1 India Chemotherapy-Induced Nausea and Vomiting Drugs Sales Breakdown by Type (2016-2021) 11.2.2 India Chemotherapy-Induced Nausea and Vomiting Drugs Sales Breakdown by Type (2022-2027) 11.3 India Chemotherapy-Induced Nausea and Vomiting Drugs Sales Breakdown by Application 11.3.1 India Chemotherapy-Induced Nausea and Vomiting Drugs Sales Breakdown by Application (2016-2021) 11.3.2 India Chemotherapy-Induced Nausea and Vomiting Drugs Sales Breakdown by Application (2022-2027) 12 Company Profiles and Key Figures in Chemotherapy-Induced Nausea and Vomiting Drugs Business 12.1 Merck & Co., Inc. 12.1.1 Merck & Co., Inc. Corporation Information 12.1.2 Merck & Co., Inc. Business Overview 12.1.3 Merck & Co., Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue and Gross Margin (2016-2021) 12.1.4 Merck & Co., Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Products Offered 12.1.5 Merck & Co., Inc. Recent Development 12.2 GlaxoSmithKline plc 12.2.1 GlaxoSmithKline plc Corporation Information 12.2.2 GlaxoSmithKline plc Business Overview 12.2.3 GlaxoSmithKline plc Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue and Gross Margin (2016-2021) 12.2.4 GlaxoSmithKline plc Chemotherapy-Induced Nausea and Vomiting Drugs Products Offered 12.2.5 GlaxoSmithKline plc Recent Development 12.3 Tesaro, Inc. 12.3.1 Tesaro, Inc. Corporation Information 12.3.2 Tesaro, Inc. Business Overview 12.3.3 Tesaro, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue and Gross Margin (2016-2021) 12.3.4 Tesaro, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Products Offered 12.3.5 Tesaro, Inc. Recent Development 12.4 Helsinn Group 12.4.1 Helsinn Group Corporation Information 12.4.2 Helsinn Group Business Overview 12.4.3 Helsinn Group Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue and Gross Margin (2016-2021) 12.4.4 Helsinn Group Chemotherapy-Induced Nausea and Vomiting Drugs Products Offered 12.4.5 Helsinn Group Recent Development 12.5 F. Hoffmann-La Roche Ltd. 12.5.1 F. Hoffmann-La Roche Ltd. Corporation Information 12.5.2 F. Hoffmann-La Roche Ltd. Business Overview 12.5.3 F. Hoffmann-La Roche Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue and Gross Margin (2016-2021) 12.5.4 F. Hoffmann-La Roche Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Products Offered 12.5.5 F. Hoffmann-La Roche Ltd. Recent Development 12.6 Heron Therapeutics, Inc. 12.6.1 Heron Therapeutics, Inc. Corporation Information 12.6.2 Heron Therapeutics, Inc. Business Overview 12.6.3 Heron Therapeutics, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue and Gross Margin (2016-2021) 12.6.4 Heron Therapeutics, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Products Offered 12.6.5 Heron Therapeutics, Inc. Recent Development 12.7 Dr. Reddy's Laboratories Ltd. 12.7.1 Dr. Reddy's Laboratories Ltd. Corporation Information 12.7.2 Dr. Reddy's Laboratories Ltd. Business Overview 12.7.3 Dr. Reddy's Laboratories Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue and Gross Margin (2016-2021) 12.7.4 Dr. Reddy's Laboratories Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Products Offered 12.7.5 Dr. Reddy's Laboratories Ltd. Recent Development 12.8 Acacia Pharma 12.8.1 Acacia Pharma Corporation Information 12.8.2 Acacia Pharma Business Overview 12.8.3 Acacia Pharma Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue and Gross Margin (2016-2021) 12.8.4 Acacia Pharma Chemotherapy-Induced Nausea and Vomiting Drugs Products Offered 12.8.5 Acacia Pharma Recent Development 12.9 Sun Pharmaceutical Industry Ltd. 12.9.1 Sun Pharmaceutical Industry Ltd. Corporation Information 12.9.2 Sun Pharmaceutical Industry Ltd. Business Overview 12.9.3 Sun Pharmaceutical Industry Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue and Gross Margin (2016-2021) 12.9.4 Sun Pharmaceutical Industry Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Products Offered 12.9.5 Sun Pharmaceutical Industry Ltd. Recent Development 12.10 Otsuka Holdings Co., Ltd. 12.10.1 Otsuka Holdings Co., Ltd. Corporation Information 12.10.2 Otsuka Holdings Co., Ltd. Business Overview 12.10.3 Otsuka Holdings Co., Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue and Gross Margin (2016-2021) 12.10.4 Otsuka Holdings Co., Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Products Offered 12.10.5 Otsuka Holdings Co., Ltd. Recent Development 13 Chemotherapy-Induced Nausea and Vomiting Drugs Manufacturing Cost Analysis 13.1 Chemotherapy-Induced Nausea and Vomiting Drugs Key Raw Materials Analysis 13.1.1 Key Raw Materials 13.1.2 Key Raw Materials Price Trend 13.1.3 Key Suppliers of Raw Materials 13.2 Proportion of Manufacturing Cost Structure 13.3 Manufacturing Process Analysis of Chemotherapy-Induced Nausea and Vomiting Drugs 13.4 Chemotherapy-Induced Nausea and Vomiting Drugs Industrial Chain Analysis 14 Marketing Channel, Distributors and Customers 14.1 Marketing Channel 14.2 Chemotherapy-Induced Nausea and Vomiting Drugs Distributors List 14.3 Chemotherapy-Induced Nausea and Vomiting Drugs Customers 15 Market Dynamics 15.1 Chemotherapy-Induced Nausea and Vomiting Drugs Market Trends 15.2 Chemotherapy-Induced Nausea and Vomiting Drugs Drivers 15.3 Chemotherapy-Induced Nausea and Vomiting Drugs Market Challenges 15.4 Chemotherapy-Induced Nausea and Vomiting Drugs Market Restraints 16 Research Findings and Conclusion 17 Appendix 17.1 Research Methodology 17.1.1 Methodology/Research Approach 17.1.2 Data Source 17.2 Author List 17.3 Disclaimer

List of Tables Table 1. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027) Table 2. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027) Table 3. Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Size (US$ Million) by Region: 2016 VS 2021 &2027 Table 4. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) by Region (2016-2021) Table 5. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Region (2016-2021) Table 6. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (US$ Million) Market Share by Region (2016-2021)) Table 7. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Share by Region (2016-2021) Table 8. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) Forecast by Region (2022-2027) Table 9. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share Forecast by Region (2022-2027) Table 10. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (US$ Million) Forecast by Region (2022-2027) Table 11. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Share Forecast by Region (2022-2027) Table 12. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) of Key Companies (2016-2021) Table 13. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Share by Company (2016-2021) Table 14. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (US$ Million) by Company (2016-2021) Table 15. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Share by Company (2016-2021) Table 16. Global Chemotherapy-Induced Nausea and Vomiting Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chemotherapy-Induced Nausea and Vomiting Drugs as of 2020) Table 17. Global Chemotherapy-Induced Nausea and Vomiting Drugs Average Price (USD/Unit) of Key Company (2016-2021) Table 18. Manufacturers Chemotherapy-Induced Nausea and Vomiting Drugs Manufacturing Sites and Area Served Table 19. Manufacturers Chemotherapy-Induced Nausea and Vomiting Drugs Product Type Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans Table 21. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) by Type (2016-2021) Table 22. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Share by Type (2016-2021) Table 23. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (US$ Million) Market Share by Type (2016-2021) Table 24. Global Chemotherapy-Induced Nausea and Vomiting Drugs Price (USD/Unit) by Type (2016-2021) Table 25. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Share by Type (2022-2027) Table 26. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (US$ Million) Market Share by Type (2022-2027) Table 27. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Share by Type (2022-2027) Table 28. Global Chemotherapy-Induced Nausea and Vomiting Drugs Price (USD/Unit) by Type (2022-2027) Table 29. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) by Application (2016-2021) Table 30. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Share by Application (2016-2021) Table 31. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (US$ Million) Market Share by Application (2016-2021) Table 32. Global Chemotherapy-Induced Nausea and Vomiting Drugs Price (USD/Unit) by Application (2016-2021) Table 33. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) by Application (2022-2027) Table 34. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Share by Application (2022-2027) Table 35. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (US$ Million) Market Share by Application (2022-2027) Table 36. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Share by Application (2022-2027) Table 37. Global Chemotherapy-Induced Nausea and Vomiting Drugs Price (USD/Unit) by Application (2022-2027) Table 38. North America Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) by Company (2016-2021) Table 39. North America Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Company (2016-2021) Table 40. North America Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Company (2016-2021) & (US$ Million) Table 41. North America Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Company (2016-2021) Table 42. North America Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Type (2016-2021) & (K Units) Table 43. North America Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Type (2016-2021) Table 44. North America Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Type (2022-2027) & (K Units) Table 45. North America Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Type (2022-2027) Table 46. North America Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Application (2016-2021) & (K Units) Table 47. North America Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Application (2016-2021) Table 48. North America Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Application (2022-2027) & (K Units) Table 49. North America Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Application (2022-2027) Table 50. Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) by Company (2016-2021) Table 51. Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Company (2016-2021) Table 52. Europe Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Company (2016-2021) & (US$ Million) Table 53. Europe Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Company (2016-2021) Table 54. Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Type (2016-2021) & (K Units) Table 55. Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Type (2016-2021) Table 56. Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Type (2022-2027) & (K Units) Table 57. Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Type (2022-2027) Table 58. Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Application (2016-2021) & (K Units) Table 59. Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Application (2016-2021) Table 60. Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Application (2022-2027) & (K Units) Table 61. Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Application (2022-2027) Table 62. China Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) by Company (2016-2021) Table 63. China Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Company (2016-2021) Table 64. China Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Company (2016-2021) & (US$ Million) Table 65. China Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Company (2016-2021) Table 66. China Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Type (2016-2021) & (K Units) Table 67. China Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Type (2016-2021) Table 68. China Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Type (2022-2027) & (K Units) Table 69. China Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Type (2022-2027) Table 70. China Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Application (2016-2021) & (K Units) Table 71. China Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Application (2016-2021) Table 72. China Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Application (2022-2027) & (K Units) Table 73. China Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Application (2022-2027) Table 74. Japan Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) by Company (2016-2021) Table 75. Japan Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Company (2016-2021) Table 76. Japan Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Company (2016-2021) & (US$ Million) Table 77. Japan Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Company (2016-2021) Table 78. Japan Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Type (2016-2021) & (K Units) Table 79. Japan Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Type (2016-2021) Table 80. Japan Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Type (2022-2027) & (K Units) Table 81. Japan Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Type (2022-2027) Table 82. Japan Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Application (2016-2021) & (K Units) Table 83. Japan Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Application (2016-2021) Table 84. Japan Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Application (2022-2027) & (K Units) Table 85. Japan Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Application (2022-2027) Table 86. Southeast Asia Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) by Company (2016-2021) Table 87. Southeast Asia Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Company (2016-2021) Table 88. Southeast Asia Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Company (2016-2021) & (US$ Million) Table 89. Southeast Asia Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Company (2016-2021) Table 90. Southeast Asia Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Type (2016-2021) & (K Units) Table 91. Southeast Asia Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Type (2016-2021) Table 92. Southeast Asia Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Type (2022-2027) & (K Units) Table 93. Southeast Asia Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Type (2022-2027) Table 94. Southeast Asia Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Application (2016-2021) & (K Units) Table 95. Southeast Asia Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Application (2016-2021) Table 96. Southeast Asia Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Application (2022-2027) & (K Units) Table 97. Southeast Asia Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Application (2022-2027) Table 98. India Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) by Company (2016-2021) Table 99. India Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Company (2016-2021) Table 100. India Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Company (2016-2021) & (US$ Million) Table 101. India Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Company (2016-2021) Table 102. India Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Type (2016-2021) & (K Units) Table 103. India Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Type (2016-2021) Table 104. India Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Type (2022-2027) & (K Units) Table 105. India Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Type (2022-2027) Table 106. India Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Application (2016-2021) & (K Units) Table 107. India Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Application (2016-2021) Table 108. India Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Application (2022-2027) & (K Units) Table 109. India Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Application (2022-2027) Table 110. Merck & Co., Inc. Corporation Information Table 111. Merck & Co., Inc. Description and Business Overview Table 112. Merck & Co., Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 113. Merck & Co., Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Product Table 114. Merck & Co., Inc. Recent Development Table 115. GlaxoSmithKline plc Corporation Information Table 116. GlaxoSmithKline plc Description and Business Overview Table 117. GlaxoSmithKline plc Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 118. GlaxoSmithKline plc Chemotherapy-Induced Nausea and Vomiting Drugs Product Table 119. GlaxoSmithKline plc Recent Development Table 120. Tesaro, Inc. Corporation Information Table 121. Tesaro, Inc. Description and Business Overview Table 122. Tesaro, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 123. Tesaro, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Product Table 124. Tesaro, Inc. Recent Development Table 125. Helsinn Group Corporation Information Table 126. Helsinn Group Description and Business Overview Table 127. Helsinn Group Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 128. Helsinn Group Chemotherapy-Induced Nausea and Vomiting Drugs Product Table 129. Helsinn Group Recent Development Table 130. F. Hoffmann-La Roche Ltd. Corporation Information Table 131. F. Hoffmann-La Roche Ltd. Description and Business Overview Table 132. F. Hoffmann-La Roche Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 133. F. Hoffmann-La Roche Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Product Table 134. F. Hoffmann-La Roche Ltd. Recent Development Table 135. Heron Therapeutics, Inc. Corporation Information Table 136. Heron Therapeutics, Inc. Description and Business Overview Table 137. Heron Therapeutics, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 138. Heron Therapeutics, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Product Table 139. Heron Therapeutics, Inc. Recent Development Table 140. Dr. Reddy's Laboratories Ltd. Corporation Information Table 141. Dr. Reddy's Laboratories Ltd. Description and Business Overview Table 142. Dr. Reddy's Laboratories Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 143. Dr. Reddy's Laboratories Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Product Table 144. Dr. Reddy's Laboratories Ltd. Recent Development Table 145. Acacia Pharma Corporation Information Table 146. Acacia Pharma Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 147. Acacia Pharma Description and Business Overview Table 148. Acacia Pharma Chemotherapy-Induced Nausea and Vomiting Drugs Product Table 149. Acacia Pharma Recent Development Table 150. Sun Pharmaceutical Industry Ltd. Corporation Information Table 151. Sun Pharmaceutical Industry Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 152. Sun Pharmaceutical Industry Ltd. Description and Business Overview Table 153. Sun Pharmaceutical Industry Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Product Table 154. Sun Pharmaceutical Industry Ltd. Recent Development Table 155. Otsuka Holdings Co., Ltd. Corporation Information Table 156. Otsuka Holdings Co., Ltd. Description and Business Overview Table 157. Otsuka Holdings Co., Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 158. Otsuka Holdings Co., Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Product Table 159. Otsuka Holdings Co., Ltd. Recent Development Table 160. Production Base and Market Concentration Rate of Raw Material Table 161. Key Suppliers of Raw Materials Table 162. Chemotherapy-Induced Nausea and Vomiting Drugs Distributors List Table 163. Chemotherapy-Induced Nausea and Vomiting Drugs Customers List Table 164. Chemotherapy-Induced Nausea and Vomiting Drugs Market Trends Table 165. Chemotherapy-Induced Nausea and Vomiting Drugs Market Drivers Table 166. Chemotherapy-Induced Nausea and Vomiting Drugs Market Challenges Table 167. Chemotherapy-Induced Nausea and Vomiting Drugs Market Restraints Table 168. Research Programs/Design for This Report Table 169. Key Data Information from Secondary Sources Table 170. Key Data Information from Primary Sources List of Figures Figure 1. Chemotherapy-Induced Nausea and Vomiting Drugs Product Picture Figure 2. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Type in 2021 & 2027 Figure 3. Existing Drugs Product Picture Figure 4. Akynzeo (Netupitant-Palonosetron FDC) Product Picture Figure 5. Aloxi (Palonosetron) Product Picture Figure 6. Emend (Aprepitant) Product Picture Figure 7. Kytril Generic (Granisetron) Product Picture Figure 8. Zofran Generic (Ondansetron) Product Picture Figure 9. Pipeline Drugs Product Picture Figure 10. SUSTOL (Granisetron Injection extended release) Product Picture Figure 11. Rolapitant Product Picture Figure 12. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Application in 2021 & 2027 Figure 13. Serotonin Receptor Antagonists Examples Figure 14. NK1 Receptor Antagonists Examples Figure 15. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales, (US$ Million), 2016 VS 2021 VS 2027 Figure 16. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Growth Rate (2016-2027) & (US$ Million) Figure 17. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) Growth Rate (2016-2027) Figure 18. Global Chemotherapy-Induced Nausea and Vomiting Drugs Price Trends Growth Rate (2016-2027) (USD/Unit) Figure 19. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Region: 2016 VS 2021 Figure 20. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Region: 2021 VS 2027 Figure 21. North America Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (Million USD) Growth Rate (2016-2027) Figure 22. North America Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) Growth Rate (2016-2027) Figure 23. Europe Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (Million USD) Growth Rate (2016-2027) Figure 24. Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales (Million USD) Growth Rate (2016-2027) Figure 25. China Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (Million USD) Growth Rate (2016-2027) Figure 26. China Chemotherapy-Induced Nausea and Vomiting Drugs Sales (Million USD) and Growth Rate (2016-2027) Figure 27. Japan Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (Million USD) Growth Rate (2016-2027) Figure 28. Japan Chemotherapy-Induced Nausea and Vomiting Drugs Sales (Million USD) Growth Rate (2016-2027) Figure 29. Southeast Asia Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (Million USD) Growth Rate (2016-2027) Figure 30. Southeast Asia Chemotherapy-Induced Nausea and Vomiting Drugs Sales (Million USD) Growth Rate (2016-2027) Figure 31. India Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (Million USD) Growth Rate (2016-2027) Figure 32. India Chemotherapy-Induced Nausea and Vomiting Drugs Sales (Million USD) Growth Rate (2016-2027) Figure 33. Global 5 Largest Chemotherapy-Induced Nausea and Vomiting Drugs Players Market Share by Revenue in Chemotherapy-Induced Nausea and Vomiting Drugs: 2016 & 2020 Figure 34. Chemotherapy-Induced Nausea and Vomiting Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 35. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Share by Type (2016-2021) Figure 36. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Growth Rate by Type in 2016 & 2020 Figure 37. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Share by Application (2016-2021) Figure 38. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Growth Rate by Application in 2016 & 2020 Figure 39. North America Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Type in 2020 Figure 40. North America Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Application in 2020 Figure 41. Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Type in 2020 Figure 42. Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Application in 2020 Figure 43. China Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Type in 2020 Figure 44. China Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Application in 2020 Figure 45. Japan Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Type in 2020 Figure 46. Japan Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Application in 2020 Figure 47. Southeast Asia Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Type in 2020 Figure 48. Southeast Asia Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Application in 2020 Figure 49. India Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Type in 2020 Figure 50. India Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Application in 2020 Figure 51. Key Raw Materials Price Trend Figure 52. Manufacturing Cost Structure of Chemotherapy-Induced Nausea and Vomiting Drugs Figure 53. Manufacturing Process Analysis of Chemotherapy-Induced Nausea and Vomiting Drugs Figure 54. Chemotherapy-Induced Nausea and Vomiting Drugs Industrial Chain Analysis Figure 55. Channels of Distribution Figure 56. Distributors Profiles Figure 57. Bottom-up and Top-down Approaches for This Report Figure 58. Data Triangulation Figure 59. Key Executives Interviewed

Merck & Co., Inc. GlaxoSmithKline plc Tesaro, Inc. Helsinn Group F. Hoffmann-La Roche Ltd. Heron Therapeutics, Inc. Dr. Reddy's Laboratories Ltd. Acacia Pharma Sun Pharmaceutical Industry Ltd. Otsuka Holdings Co., Ltd.